TIMM44 and central nervous system cancer: Remarkably, OE-TIMM44 inhibited shYME1L-induced anti-glioma cell activity (Figure 6N-P), partially restoring cell proliferation (Figure 6N) and migration (Figure 6O), and alleviating cell apoptosis (Figure 6P).